These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32834792)

  • 1. Renin-Angiotensin-Aldosterone Inhibitors and COVID-19.
    Benenson I; Waldron FA
    J Nurse Pract; 2020; 16(7):545-546. PubMed ID: 32834792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR; Rolfe M
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
    Emdin M; Fatini C; Mirizzi G; Poletti R; Borrelli C; Prontera C; Latini R; Passino C; Clerico A; Vergaro G
    Clin Chim Acta; 2015 Mar; 443():85-93. PubMed ID: 25445411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions amongst inflammation, renin-angiotensin-aldosterone and kallikrein-kinin systems: suggestive approaches for COVID-19 therapy.
    Oliveira LCG; Cruz NAN; Ricelli B; Tedesco-Silva H; Medina-Pestana JO; Casarini DE
    J Venom Anim Toxins Incl Trop Dis; 2021; 27():e20200181. PubMed ID: 34925477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
    Bavishi C; Bangalore S; Messerli FH
    Prog Cardiovasc Dis; 2016; 59(3):253-261. PubMed ID: 27777044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease.
    Gupta G; Dahiya R; Singh Y; Mishra A; Verma A; Gothwal SK; Aljabali AAA; Dureja H; Prasher P; Negi P; Kapoor DN; Goyal R; Tambuwala MM; Chellappan DK; Dua K
    Chem Biol Interact; 2020 Feb; 317():108975. PubMed ID: 32032593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
    van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
    J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.
    Atlas SA
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl B):9-20. PubMed ID: 17970613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin angiotensin aldosterone system and COVID-19.
    Alsufyani HA; Docherty JR
    Saudi Pharm J; 2020 Aug; 28(8):977-984. PubMed ID: 32788834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients.
    Trošt Rupnik A; Pajek J; Guček A; Osredkar J; Kovač D; Bren A; Klančič D; Saksida S; Rus I; Globokar M; Drozg A; Lešnik M; Plešivčnik Z; Ekart R; Lopert S; Lindič J
    Ther Apher Dial; 2013 Aug; 17(4):425-30. PubMed ID: 23931884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
    Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.
    Turgut F; Balogun RA; Abdel-Rahman EM
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1330-9. PubMed ID: 20498247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
    Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current strategies to achieve further cardiac and renal protection through enhanced renin-angiotensin-aldosterone system inhibition.
    Alfie J; Aparicio LS; Waisman GD
    Rev Recent Clin Trials; 2011 May; 6(2):134-46. PubMed ID: 21241234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study.
    Villard O; Morquin D; Molinari N; Raingeard I; Nagot N; Cristol JP; Jung B; Roubille C; Foulongne V; Fesler P; Lamure S; Taourel P; Konate A; Maria ATJ; Makinson A; Bertchansky I; Larcher R; Klouche K; Le Moing V; Renard E; Guilpain P
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern?
    Yildirim T; Arici M; Piskinpasa S; Aybal-Kutlugun A; Yilmaz R; Altun B; Erdem Y; Turgan C
    Ren Fail; 2012; 34(9):1095-9. PubMed ID: 22950572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system.
    Nishiyama A; Kim-Mitsuyama S
    J Pharmacol Sci; 2010; 113(4):289-91. PubMed ID: 20675960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.